Kenta Teruya

5PUBLICATIONS
3CO-AUTHORS
Medical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsToxicology (incl. clinical toxicology)Characterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 18, 2026
Involvement of the spleen in the anti-prion activity of hydroxypropyl methylcellulose in mice.

Kenta Teruya, Ayumi Oguma, Keiko Nishizawa

|Jan 25, 2025
Correction: Awahara et al. The Effects of Side-Chain Configurations of a Retro-Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease. Molecules 2022, 27, 1646.

Chiyuki Awahara, Daiki Oku, Saki Furuta

|Dec 19, 2023
Combination of Styrylbenzoazole Compound and Hydroxypropyl Methylcellulose Enhances Therapeutic Effect in Prion-Infected Mice.

Kenta Teruya, Ayumi Oguma, Sara Iwabuchi

|Mar 10, 2022
The Effects of Side-Chain Configurations of a Retro-Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease.

Chiyuki Awahara, Daiki Oku, Saki Furuta

|Dec 16, 2016
A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents.

Kenta Teruya, Ayumi Oguma, Keiko Nishizawa

Pageof 1

Frequent Collaborators

2 joint publications

Kazuya Kobayashi

2 joint publications

Katsumi Doh-Ura

1 joint publications

Hiroshi Kamitakahara